Cuprina Holdings (Cayman) LTD Logo

Cuprina Holdings (Cayman) LTD

Biomedical firm specializing in Maggot Debridement Therapy for wound care in Singapore & Hong Kong.

CUPR | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
BLOCK 1090, 169201 SINGAPORE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cuprina Holdings is a biomedical and biotechnology company specializing in the development and commercialization of innovative wound care solutions and cosmeceuticals. The company's primary focus is on Maggot Debridement Therapy (MDT), a biotherapy for chronic wounds like diabetic foot ulcers. Its flagship product, MEDIFLY, uses medical-grade sterile larvae for the non-surgical removal of necrotic tissue, offering a clinically-proven alternative to conventional treatments with demonstrated higher healing rates and faster debridement. The company's portfolio also includes collagen-based wound care products and a range of skin restoration balms and athletic care products. Cuprina primarily serves healthcare providers and patients in Singapore and Hong Kong.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cuprina Holdings (Cayman) LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cuprina Holdings (Cayman) LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cuprina Holdings (Cayman) LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
MANNKIND CORP Logo
Develops inhaled therapies for endocrine, orphan lung, and cardiometabolic diseases.
United States of America MNKD
MARAVAI LIFESCIENCES HOLDINGS, INC. Logo
Provides nucleic acid products and biologics safety testing for new therapies and vaccines.
United States of America MRVI
Marinomed Biotech AG Logo
Develops virus-blocking products & immunology therapies via proprietary technology platforms.
Austria MARI
Marker Therapeutics, Inc. Logo
Developing non-genetically modified T cell immunotherapies for hematologic and solid tumors.
United States of America MRKR
Matinas BioPharma Holdings, Inc. Logo
Developing oral drugs via a lipid nano-crystal platform for infections, oncology & inflammation.
United States of America MTNB
Matricelf Ltd. Logo
Develops personalized 3D neural implants from patient cells to treat spinal cord injuries.
Israel MTLF
Maze Therapeutics, Inc. Logo
Develops genetic precision medicines for common diseases, with a focus on chronic kidney disease.
United States of America MAZE
MBX Biosciences, Inc. Logo
Developing novel peptide therapies for underserved endocrine and metabolic disorders.
United States of America MBX
MDxHealth SA Logo
Provides actionable molecular diagnostics for urologic diseases, specializing in prostate cancer.
United States of America MDXH
Median Diagnostics Inc. Logo
Manufactures veterinary IVD kits & raw materials to diagnose infectious animal diseases.
South Korea 233250

Talk to a Data Expert

Have a question? We'll get back to you promptly.